Skip to content

A study in healthy subjects investigating the safety, tolerability and concentrations of FE 999301 after single and multiple doses

Status
Completed
Phases
Phase 1
Study type
Interventional
Source
EU CTIS
Registry ID
CTIS2023-507882-24-00
Acronym
000414
Enrollment
48
Registered
2024-02-08
Start date
2024-02-20
Completion date
2024-11-15
Last updated
2024-02-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Inflammatory Gastrointestinal Disease

Interventions

None listed

Sponsors

Ferring Pharmaceuticals A/S
Lead SponsorINDUSTRY

Eligibility

Sex/Gender
Male
Age
18 Years to 64 Years

Countries

Germany

Outcome results

None listed

Source: EU CTIS · Data processed: Feb 4, 2026